Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.
May 3, 2022
0
10
South Africa's health products regulator said on Thursday it had approved the use of Merck's COVID-19 pill for high-risk adults.
Feb 17, 2022
0
4
The world is becoming "better prepared" to deal with future variants of the coronavirus, the CEO and co-founder of German vaccine-maker BioNTech told AFP Thursday, as the company works on an Omicron-specific shot.
Feb 17, 2022
0
32
Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.
Jul 13, 2016
0
0
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Oct 5, 2012
0
0
(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.
Sep 3, 2012
0
0
Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.
Feb 27, 2012
0
0
(AP) -- Johnson & Johnson's longtime CEO Bill Weldon is stepping down as the health care giant's top executive after an embarrassing string of recalls of everything from Tylenol to Benadryl that has cost the company hundreds ...
Feb 22, 2012
0
0
